Literature DB >> 23964132

Precision medicine for cancer patients: lessons learned and the path forward.

Adi F Gazdar, John D Minna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23964132      PMCID： PMC3760782          DOI： 10.1093/jnci/djt219

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  Predictive and prognostic factors for non-small cell lung cancer--potholes in the road to the promised land.

Authors:  Adi F Gazdar; Joan H Schiller
Journal:  J Natl Cancer Inst       Date:  2011-12-08       Impact factor: 13.506

2.  Clinical medicine. Biomarker tests need closer scrutiny, IOM concludes.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2012-03-30       Impact factor: 47.728

3.  Microarrays: retracing steps.

Authors:  Kevin R Coombes; Jing Wang; Keith A Baggerly
Journal:  Nat Med       Date:  2007-11       Impact factor: 53.440

4.  What information should be required to support clinical "omics" publications?

Authors:  Keith A Baggerly; Kevin R Coombes
Journal:  Clin Chem       Date:  2011-05       Impact factor: 8.327

5.  The clinical relevance of cancer cell lines.

Authors:  Jean-Pierre Gillet; Sudhir Varma; Michael M Gottesman
Journal:  J Natl Cancer Inst       Date:  2013-02-21       Impact factor: 13.506

Review 6.  Lung cancer cell lines as tools for biomedical discovery and research.

Authors:  Adi F Gazdar; Luc Girard; William W Lockwood; Wan L Lam; John D Minna
Journal:  J Natl Cancer Inst       Date:  2010-08-02       Impact factor: 13.506

Review 7.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

8.  Towards patient-based cancer therapeutics.

Authors:  Stuart L Schreiber; Alykhan F Shamji; Paul A Clemons; Cindy Hon; Angela N Koehler; Benito Munoz; Michelle Palmer; Andrew M Stern; Bridget K Wagner; Scott Powers; Scott W Lowe; Xuecui Guo; Alex Krasnitz; Eric T Sawey; Raffaella Sordella; Lincoln Stein; Lloyd C Trotman; Andrea Califano; Riccardo Dalla-Favera; Adolfo Ferrando; Antonio Iavarone; Laura Pasqualucci; José Silva; Brent R Stockwell; William C Hahn; Lynda Chin; Ronald A DePinho; Jesse S Boehm; Shuba Gopal; Alan Huang; David E Root; Barbara A Weir; Daniela S Gerhard; Jean Claude Zenklusen; Michael G Roth; Michael A White; John D Minna; John B MacMillan; Bruce A Posner
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

9.  Independent validation of a model using cell line chemosensitivity to predict response to therapy.

Authors:  Wenting Wang; Keith A Baggerly; Steen Knudsen; Jon Askaa; Wiktor Mazin; Kevin R Coombes
Journal:  J Natl Cancer Inst       Date:  2013-08-20       Impact factor: 13.506

10.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962
  10 in total
  7 in total

1.  Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers.

Authors:  Qi Liu; Meng Wang; Ashley M Kern; Saman Khaled; Jing Han; Beow Y Yeap; Theodore S Hong; Jeff Settleman; Cyril H Benes; Kathryn D Held; Jason A Efstathiou; Henning Willers
Journal:  Mol Cancer Res       Date:  2015-02-09       Impact factor: 5.852

2.  An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.

Authors:  Luc Girard; Jaime Rodriguez-Canales; Carmen Behrens; Debrah M Thompson; Ihab W Botros; Hao Tang; Yang Xie; Natasha Rekhtman; William D Travis; Ignacio I Wistuba; John D Minna; Adi F Gazdar
Journal:  Clin Cancer Res       Date:  2016-06-28       Impact factor: 12.531

3.  Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Patricia A Deverka; John B Watkins; Kathryn A Phillips
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

4.  Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

Authors:  Julia R Trosman; Christine B Weldon; R Kate Kelley; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

5.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

6.  Precision medicine: opportunities, possibilities, and challenges for patients and providers.

Authors:  Samantha A Adams; Carolyn Petersen
Journal:  J Am Med Inform Assoc       Date:  2016-03-14       Impact factor: 7.942

7.  Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.

Authors:  J Fang; C Cai; Q Wang; P Lin; Z Zhao; F Cheng
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.